News

Public · Published

Wells Fargo maintains Hinge Health at Overweight, raises price target to $132 from $103

Wells Fargo kept an Overweight rating on Hinge Health and raised its price target to $132 from $103, a 28.2% increase. That target implies 14.3% upside from the November 2 close of $115.48.

Published:

Updated:

What happened

Wells Fargo kept an Overweight rating on Hinge Health and raised its price target to $132 from $103, a 28.2% increase. That target implies 14.3% upside from the November 2 close of $115.48.

Confirmed

Global impact / market context

A higher target signals Wells Fargo expects more share price gain. Because a target is only a forecast, it does not guarantee returns. It may draw investor attention to Hinge Health and support demand for the stock.

Analyst inference

Other recent analyst notes set targets from $134 to $150, all above Wells Fargo's new figure. That clustering suggests broadly positive expectations across research firms, though targets vary and remain opinions rather than commitments.

Analyst inference

What to watch

  1. Watch whether Hinge Health shares move toward the $132 target from the $115.48 close, a gap of 14.3% that the note describes as implied upside. Confirmed
  2. Watch whether other analysts change their ratings or targets, since current targets ranging from $134 to $150 sit above Wells Fargo's new $132 level. Proposed
  3. Watch the company's next results for revenue and cost trends, because analyst targets depend on profit expectations that can shift after new financial disclosures. Analyst inference

Evidence

  • Original source link unavailable